Your prediction
ALS Ltd Stock
Heavy losses for ALS Ltd today as the stock fell by -€0.600 (-5.040%).
Pros and Cons of ALS Ltd in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ALS Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ALS Ltd | -5.040% | -7.752% | -16.783% | 36.000% | -4.032% | 72.464% | 85.938% |
| Downer EDI Ltd | -1.780% | 0.446% | -1.316% | 45.161% | 1.351% | 118.447% | 35.542% |
| Seek Ltd | 1.160% | -5.495% | -11.340% | -35.338% | -34.351% | -40.690% | -51.136% |
| Fti Consulting | -0.670% | 5.634% | 10.294% | 1.351% | 2.740% | -15.254% | 32.743% |
News
North American Niobium Highlights 0.150% Nb2O5 with 124.53 ppm Dy2O3 from Pegmatite Grab Sample and 0.19% TREO from REE-Bearing Carbonatite Outcrop at Seigneurie, Québec
Vancouver, British Columbia – February 17, 2026 – North American Niobium and Critical Minerals Corp. (CSE: NIOB) (OTCQB: NIOMF) (FSE: KS82.F) (“North American Niobium” or the “Company”) is
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities
- This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages
RE-Transmission: Vanguard Mining Reports Re-Assay Program for Redonda Copper-Molybdenum Project
Vancouver, BC – January 30, 2026 – Vanguard Mining Corp. ("Vanguard" or the "Company") (CSE: UUU | OTC: UUUFF | FSE: SL51) is pleased to announce that the Company plans to undertake